Perceptive Advisors as of June 30, 2020
Portfolio Holdings for Perceptive Advisors
Perceptive Advisors holds 124 positions in its portfolio as reported in the June 2020 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Amicus Therapeutics (FOLD) | 6.2 | $380M | 25M | 15.08 | |
Global Blood Therapeutics In | 6.0 | $369M | 5.8M | 63.13 | |
Retrophin Note 2.500% 9/1 (Principal) | 5.7 | $350M | 45M | 7.78 | |
Iovance Biotherapeutics (IOVA) | 5.3 | $324M | 12M | 27.45 | |
Mirati Therapeutics | 5.1 | $316M | 2.8M | 114.17 | |
Neurocrine Biosciences (NBIX) | 4.2 | $261M | 2.1M | 122.00 | |
Cytokinetics Note 4.000%11/1 (Principal) | 3.9 | $238M | 10M | 23.83 | |
Bridgebio Pharma (BBIO) | 3.5 | $219M | 6.7M | 32.61 | |
Kodiak Sciences (KOD) | 3.1 | $190M | 3.5M | 54.12 | |
Vbi Vaccines Com New | 2.8 | $171M | 55M | 3.10 | |
Collegium Pharmaceutical Note 2.625% 2/1 (Principal) | 2.5 | $157M | 18M | 8.98 | |
Athenex | 2.5 | $156M | 12M | 13.52 | |
Springworks Therapeutics (SWTX) | 2.4 | $148M | 3.5M | 42.00 | |
Myokardia | 2.2 | $135M | 1.4M | 96.62 | |
Zogenix Com New | 2.1 | $133M | 4.9M | 27.01 | |
Zymeworks | 2.1 | $129M | 3.6M | 36.07 | |
Nevro Corp Note 2.750% 4/0 (Principal) | 2.0 | $122M | 9.0M | 13.50 | |
Nevro (NVRO) | 1.7 | $108M | 900k | 119.47 | |
Quotient | 1.6 | $98M | 13M | 7.40 | |
Meiragtx Holdings (MGTX) | 1.3 | $81M | 6.4M | 12.52 | |
Kadmon Hldgs | 1.3 | $80M | 16M | 5.12 | |
Frequency Therapeutics | 1.1 | $71M | 3.0M | 23.25 | |
Arena Pharmaceuticals Com New | 1.1 | $69M | 1.1M | 62.95 | |
Allogene Therapeutics (ALLO) | 1.1 | $66M | 1.5M | 42.82 | |
Provention Bio | 1.0 | $64M | 4.5M | 14.11 | |
Crinetics Pharmaceuticals In (CRNX) | 1.0 | $59M | 3.7M | 16.17 | |
Forma Therapeutics Hldgs SHS | 0.9 | $58M | 1.3M | 46.49 | |
Vapotherm | 0.9 | $55M | 1.3M | 40.99 | |
Blueprint Medicines (BPMC) | 0.9 | $54M | 689k | 78.00 | |
Albireo Pharma | 0.8 | $52M | 2.0M | 26.49 | |
Neptune Wellness Solutions I | 0.8 | $52M | 18M | 2.80 | |
Adma Biologics (ADMA) | 0.8 | $49M | 17M | 2.93 | |
Agios Pharmaceuticals (AGIO) | 0.8 | $48M | 900k | 53.48 | |
Rocket Pharmaceuticals (RCKT) | 0.7 | $46M | 2.2M | 20.93 | |
Zentalis Pharmaceuticals (ZNTL) | 0.7 | $46M | 1.1M | 43.60 | |
Agile Therapeutics | 0.7 | $44M | 16M | 2.78 | |
Black Diamond Therapeutics (BDTX) | 0.7 | $44M | 1.1M | 39.83 | |
Menlo Therapeutics | 0.6 | $40M | 23M | 1.73 | |
Verrica Pharmaceuticals (VRCA) | 0.6 | $38M | 3.4M | 11.01 | |
Lyra Therapeutics (LYRA) | 0.6 | $37M | 3.2M | 11.34 | |
Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 0.6 | $36M | 2.1M | 17.50 | |
Macrogenics (MGNX) | 0.6 | $36M | 1.3M | 27.92 | |
Fusion Pharmaceuticals | 0.6 | $36M | 2.2M | 16.08 | |
Molecular Templates | 0.6 | $34M | 2.5M | 13.79 | |
Inari Medical Ord (NARI) | 0.5 | $34M | 696k | 48.44 | |
Dbv Technologies S A Sponsored Adr | 0.5 | $32M | 7.3M | 4.39 | |
Avidity Biosciences Ord (RNA) | 0.5 | $32M | 1.2M | 25.58 | |
Eidos Therapeutics | 0.5 | $30M | 687k | 43.84 | |
Geron Corporation (GERN) | 0.5 | $29M | 14M | 2.18 | |
Novavax Com New (NVAX) | 0.5 | $29M | 350k | 83.35 | |
Retrophin | 0.5 | $29M | 3.2M | 8.91 | |
Vaxcyte (PCVX) | 0.4 | $27M | 850k | 31.61 | |
Immunovant (IMVT) | 0.4 | $27M | 1.1M | 24.35 | |
AtriCure (ATRC) | 0.4 | $24M | 529k | 44.95 | |
Urovant Sciences | 0.4 | $23M | 2.4M | 9.84 | |
Adaptive Biotechnologies Cor (ADPT) | 0.4 | $23M | 480k | 48.38 | |
Cytomx Therapeutics (CTMX) | 0.3 | $22M | 2.6M | 8.33 | |
Concert Pharmaceuticals I equity | 0.3 | $21M | 2.2M | 9.95 | |
Turning Point Therapeutics I | 0.3 | $21M | 330k | 64.59 | |
Denali Therapeutics | 0.3 | $21M | 850k | 24.18 | |
Dicerna Pharmaceuticals | 0.3 | $20M | 800k | 25.40 | |
Solid Biosciences | 0.3 | $20M | 6.7M | 2.93 | |
Iveric Bio | 0.3 | $18M | 3.5M | 5.10 | |
Morphic Hldg (MORF) | 0.3 | $18M | 650k | 27.05 | |
Leap Therapeutics | 0.3 | $18M | 8.5M | 2.06 | |
Immunomedics | 0.3 | $16M | 462k | 35.44 | |
Mylan Shs Euro | 0.3 | $16M | 1.0M | 16.08 | |
Silk Road Medical Inc Common | 0.3 | $16M | 385k | 41.89 | |
Stoke Therapeutics (STOK) | 0.3 | $16M | 672k | 23.83 | |
Fulcrum Therapeutics (FULC) | 0.3 | $16M | 894k | 17.64 | |
Y Mabs Therapeutics (YMAB) | 0.2 | $15M | 355k | 43.20 | |
Establishment Labs Holdings SHS (ESTA) | 0.2 | $14M | 736k | 18.68 | |
Hologic (HOLX) | 0.2 | $13M | 230k | 57.00 | |
Aldeyra Therapeutics (ALDX) | 0.2 | $13M | 3.1M | 4.17 | |
Alector (ALEC) | 0.2 | $13M | 512k | 24.44 | |
Twist Bioscience Corp (TWST) | 0.2 | $12M | 273k | 45.30 | |
Bellus Health Com New | 0.2 | $12M | 1.1M | 10.29 | |
Revolution Medicines (RVMD) | 0.2 | $11M | 350k | 31.57 | |
Insulet Corporation (PODD) | 0.2 | $10M | 53k | 194.26 | |
Sc Health Corp Unit 99/99/9999 | 0.2 | $10M | 1.0M | 10.11 | |
Health Catalyst (HCAT) | 0.2 | $9.8M | 336k | 29.17 | |
Coherus Biosciences (CHRS) | 0.2 | $9.7M | 545k | 17.86 | |
Regeneron Pharmaceuticals (REGN) | 0.2 | $9.4M | 15k | 623.60 | |
Neoleukin Therapeutics | 0.1 | $8.9M | 537k | 16.60 | |
Aquestive Therapeutics (AQST) | 0.1 | $8.5M | 1.8M | 4.86 | |
1life Healthcare | 0.1 | $7.9M | 219k | 36.32 | |
Longview Acquisition Corp Unit 99/99/9999 | 0.1 | $7.1M | 700k | 10.10 | |
Bio Rad Labs Cl A (BIO) | 0.1 | $7.0M | 16k | 451.48 | |
Amyris Com New | 0.1 | $6.4M | 1.8M | 3.50 | |
Dermtech Ord ord (DMTKQ) | 0.1 | $6.4M | 487k | 13.23 | |
Moderna Put Option (MRNA) | 0.1 | $6.4M | 100k | 64.21 | |
Vocera Communications | 0.1 | $6.1M | 290k | 21.20 | |
Translate Bio | 0.1 | $5.6M | 315k | 17.92 | |
Motus Gi Hldgs Incorporated | 0.1 | $5.6M | 4.2M | 1.32 | |
Female Health (VERU) | 0.1 | $5.5M | 1.7M | 3.34 | |
Viewray (VRAYQ) | 0.1 | $5.5M | 2.5M | 2.24 | |
Axsome Therapeutics (AXSM) | 0.1 | $4.1M | 50k | 82.28 | |
Burning Rock Biotech Sponsored Ads | 0.1 | $4.1M | 150k | 27.01 | |
Adaptimmune Therapeutics Sponds Adr (ADAP) | 0.1 | $4.0M | 400k | 10.01 | |
Lifesci Acquisition Corp Unit 03/31/2025 | 0.1 | $3.3M | 300k | 11.00 | |
Alphatec Hldgs Com New (ATEC) | 0.0 | $2.6M | 562k | 4.70 | |
Galera Therapeutics (GRTX) | 0.0 | $2.3M | 325k | 7.14 | |
Phreesia (PHR) | 0.0 | $2.0M | 70k | 28.27 | |
Medtronic SHS (MDT) | 0.0 | $1.8M | 20k | 91.70 | |
Revance Therapeutics (RVNC) | 0.0 | $1.6M | 66k | 24.42 | |
Dynavax Technologies Corp Com New (DVAX) | 0.0 | $1.6M | 177k | 8.87 | |
Eiger Biopharmaceuticals | 0.0 | $1.3M | 140k | 9.60 | |
Legend Biotech Corp Sponsored Ads (LEGN) | 0.0 | $1.1M | 25k | 42.56 | |
Ferrari SHS (RACE) | 0.0 | $1.1M | 6.2k | 170.97 | |
Livongo Health | 0.0 | $1.0M | 14k | 75.18 | |
Momenta Pharmaceuticals | 0.0 | $1.0M | 31k | 33.26 | |
Trillium Therapeutics Com New | 0.0 | $928k | 115k | 8.09 | |
Sierra Oncology Com New | 0.0 | $807k | 67k | 12.11 | |
Karuna Therapeutics Ord | 0.0 | $774k | 6.9k | 111.46 | |
Akebia Therapeutics (AKBA) | 0.0 | $716k | 53k | 13.58 | |
Repro-Med Systems (KRMD) | 0.0 | $672k | 75k | 8.98 | |
Cue Biopharma (CUE) | 0.0 | $646k | 26k | 24.50 | |
Luminex Corporation | 0.0 | $616k | 19k | 32.55 | |
Chemocentryx | 0.0 | $590k | 10k | 57.55 | |
Tg Therapeutics (TGTX) | 0.0 | $580k | 30k | 19.49 | |
Vir Biotechnology (VIR) | 0.0 | $534k | 13k | 41.00 | |
Apellis Pharmaceuticals (APLS) | 0.0 | $373k | 11k | 32.67 | |
Avadel Pharmaceuticals Sponsored Adr | 0.0 | $133k | 8.7k | 15.32 | |
Outlook Therapeutics *w Exp 02/18/202 | 0.0 | $108k | 421k | 0.26 |